Short vs Extended Treatment With a Carbapenem in Patients With High-Risk Fever of Unknown Origin During Neutropenia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial
Lancet Haematol 2022 Jun 09;[EPub Ahead of Print], NA de Jonge, JJ Sikkens, S Zweegman, A Beeker, P Ypma, AH Herbers, W Vasmel, A de Kreuk, JLLM Coenen, B Lissenberg-Witte, MHH Kramer, MA van Agtmael, JJWM JanssenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.